Legion Consortium Ltd
HKEX:2129
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Legion Consortium Ltd
HKEX:2129
|
SG |
|
Ilsung Pharmaceutical Co Ltd
KRX:003120
|
KR |
|
G
|
Gadsden Properties Inc
OTC:GADS
|
US |
Income Statement
Earnings Waterfall
Legion Consortium Ltd
Income Statement
Legion Consortium Ltd
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Revenue |
46
N/A
|
51
+11%
|
57
+12%
|
62
+9%
|
60
-3%
|
60
-1%
|
66
+10%
|
64
-3%
|
|
| Gross Profit | |||||||||
| Cost of Revenue |
(32)
|
(37)
|
(39)
|
(41)
|
(41)
|
(41)
|
(45)
|
(44)
|
|
| Gross Profit |
13
N/A
|
14
+8%
|
18
+26%
|
21
+17%
|
19
-10%
|
19
-2%
|
21
+11%
|
20
-3%
|
|
| Operating Income | |||||||||
| Operating Expenses |
(9)
|
(10)
|
(13)
|
(15)
|
(14)
|
(14)
|
(15)
|
(19)
|
|
| Selling, General & Administrative |
(9)
|
(10)
|
(13)
|
(15)
|
(13)
|
(13)
|
(14)
|
(18)
|
|
| Depreciation & Amortization |
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
|
| Other Operating Expenses |
1
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| Operating Income |
4
N/A
|
5
+13%
|
5
+12%
|
6
+15%
|
5
-22%
|
5
-1%
|
5
+18%
|
1
-79%
|
|
| Pre-Tax Income | |||||||||
| Interest Income Expense |
0
|
0
|
0
|
(0)
|
(0)
|
0
|
1
|
(0)
|
|
| Non-Reccuring Items |
(1)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
4
N/A
|
5
+43%
|
6
+4%
|
6
+6%
|
4
-24%
|
5
+5%
|
6
+27%
|
1
-81%
|
|
| Net Income | |||||||||
| Tax Provision |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Income from Continuing Operations |
3
|
4
|
5
|
5
|
3
|
4
|
5
|
0
|
|
| Income to Minority Interest |
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Net Income (Common) |
3
N/A
|
4
+56%
|
5
+2%
|
5
+7%
|
3
-29%
|
4
+6%
|
5
+38%
|
0
-96%
|
|
| EPS (Diluted) |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|